相关实验视频

Updated: Jan 10, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

机器学习驱动的癌细胞表型的整合预测了 Cisplatin 的敏感性

Haruki Ujiie^1,2, Tomoko Sakyo², Konomi Oya²

¹Department of Pharmacy, Iwate Medical University Hospital, Shiwa-gun, Iwate, Japan.

Cancer medicine

|November 20, 2025

概括

这项研究引入了一种机器学习模型,使用基因表达来预测患者对诸如西斯等经典化疗药物的反应. 这种方法增强了精准医学,以更有效地治疗癌症.

科学领域:

在瘤学瘤学.
生物信息学是一种生物信息学.
基因组学就是基因组学.

背景情况:

精准医学已经彻底改变了癌症治疗,主要是通过针对性药物和免疫疗法的基因组分析.
目前的基因组测试在预测传统抗癌剂的疗效方面是有限的.
建议使用基因表达的基于表型的新型分类方法来预测经典抗癌剂的有效性.

研究的目的:

开发一种机器学习模型,以基于基因表达模式来预测对经典抗癌剂的敏感性.
为个性化化疗选择建立基于表型的分类系统.

主要方法:

对IC50值进行分层分类,以区分对西斯普拉丁敏感和耐药的细胞系.
差异表达基因 (DEG) 分析与基于SHAP值的机器学习相结合,以确定关键的预测基因.
使用26基因 (CSP26G) 模型开发西斯普拉丁敏感性预测器.

主要成果:

通过CSP26G模型,在抗西斯普拉丁细胞系 (A549CR) 中证明了外部有效性.
该模型成功地将TCGA的非小细胞肺癌患者分为敏感和耐药组,与生存结果相关联.
CSP26G 显示了对西斯普拉丁和其他破坏DNA的药物的预测能力.

结论:

整合DEG分析和机器学习使得一个强大的药物敏感性预测模型成为可能.
这个模型推进了经典化疗的个性化精密医学.
这些发现支持基于基因表达的预测用于优化化疗方案的临床应用.

关键词:

在RNA-seqq.人工智能的人工智能是人工智能.生物标志物生物标志物有效性有效性有效性.肺癌是一种肺癌.

更多相关视频

Author Spotlight: Shear Assay Protocol for the Determination of Single-Cell Material Properties

Author Spotlight: Shear Assay Protocol for the Determination of Single-Cell Material Properties

Published on: May 19, 2023

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...